Genmab Net Total Equity Issued/Repurchased 2019-2025 | GMAB
Genmab net total equity issued/repurchased for the twelve months ending March 31, 2025 was $-1.604B, a 520.02% increase year-over-year.
- Genmab annual net total equity issued/repurchased for 2024 was $-0.544B, a 808.95% increase from 2023.
- Genmab annual net total equity issued/repurchased for 2023 was $-0.06B, a 32.73% decline from 2022.
- Genmab annual net total equity issued/repurchased for 2022 was $-0.089B, a 79.14% increase from 2021.